Pancreatic Cancer Research

ResearcherDalhousie UniversityNo recent work listed

Jessie Kang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9959-2071; OpenAlex author ID A5036396997. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper · 2023: 1 paper

Papers 4

  1. Can we rely on contrast-enhanced CT to identify pancreatic ductal adenocarcinoma? A population-based study in sensitivity and factors associated with false neg… First author DOI 10.1007/s00330-023-09758-y↗
  2. Transabdominal ultrasound of pancreatic ductal adenocarcinoma: A multi-centered population-based study in sensitivity, associated diagnostic intervals, and sur… Co-author DOI 10.1067/j.cpradiol.2022.04.007↗
  3. The implications of missed or misinterpreted cases of pancreatic ductal adenocarcinoma on imaging: a multi-centered population-based study. Co-author DOI 10.1007/s00330-020-07120-0↗
  4. Factors associated with missed and misinterpreted cases of pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00330-020-07307-5↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andreu F. Costa · 4 shared papers, 2021–2023 · strength 0.95
  2. Sharon E. Clarke · 2 shared papers, 2021 · strength 0.38
  3. Max LeBlanc · 1 shared paper, 2023 · strength 0.31
  4. Ravi Ramjeesingh · 1 shared paper, 2021 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.